Tobramycin
Systemic: Complicated and recurrent UTIs due to Pseudomonas aeruginosa, Proteus, Escherichia coli, Klebsiella, Enterobacter, Serratia, Staphylococcus aureus, Citrobacter, and Providencia. Lower respiratory tract infections due to P. aeruginosa, Klebsiella, Enterobacter, E. coli, Serratia, and S. aureus. Intra-abdominal infections (including peritonitis) due to E. coli, Klebsiella, and Enterobacter. Septicemia in neonates, children, and adults due to P. aeruginosa, E. coli, and Klebsiella. Skin, bone, and skin structure infections due to P. aeruginosa, Proteus, E. coli, Klebsiella, Enterobacter, and S. aureus. Serious CNS infections, including meningitis. Can be used with penicillins or cephalosporins in serious infections when results of susceptibility testing are not yet known.
Ophthalmic: Treat superficial ocular infections due to Staphylococcus, S. aureus, Streptococcus, S. pneumoniae, beta-hemolytic streptococci, Corynebacterium, E. coli, Haemophilus aegyptius, H. ducreyi, H. influenzae, H. parainfluenzae, Klebsiella pneumoniae, Neisseria, N. gonorrhoeae, Proteus, Acinetobacter calcoaceticus, Enterobacter, Enterobacter aerogenes, Serratia marcescens, Moraxella, Pseudomonas aeruginosa, and Vibrio
Sumatriptan
Treatment of acute migraine attacks with or without aura. Photophobia, phonophobia, nausea, and vomiting associated with migraine attacks are also relieved. The drug is intended to relieve migraine, but not to prevent or reduce the number of attacks experienced. Treatment of cluster headaches